190 related articles for article (PubMed ID: 15225429)
1. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
2. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
[TBL] [Abstract][Full Text] [Related]
3. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
4. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
5. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
6. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease.
Takeda S; Kondo M; Kumada T; Koshikawa T; Ueda R; Nishio M; Osada H; Suzuki H; Nagatake M; Washimi O; Takagi K; Takahashi T; Nakao A; Takahashi T
Oncogene; 1996 Apr; 12(7):1589-92. PubMed ID: 8622877
[TBL] [Abstract][Full Text] [Related]
7. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
[TBL] [Abstract][Full Text] [Related]
10. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell].
Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580
[TBL] [Abstract][Full Text] [Related]
11. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
Wu J; Qin Y; Li B; He WZ; Sun ZL
Genomics; 2008 May; 91(5):443-50. PubMed ID: 18358696
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
15. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
[TBL] [Abstract][Full Text] [Related]
16. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma.
Iizuka N; Oka M; Tamesa T; Hamamoto Y; Yamada-Okabe H
Anticancer Res; 2004; 24(6):4085-9. PubMed ID: 15736456
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
18. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
Wu HK; Squire JA; Catzavelos CG; Weksberg R
Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level.
Sohda T; Yun K; Iwata K; Soejima H; Okumura M
Lab Invest; 1996 Sep; 75(3):307-11. PubMed ID: 8804354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
